|B. Riley FBR||Mayank Mamtani|
|Cantor Fitzgerald||Charles Duncan, PhD|
|H.C. Wainwright & Co.||Vernon Bernardino|
|Jefferies||Kelechi Chikere, PhD|
|JP Morgan||Eric Joseph, PhD|
The analysts listed above follow Novavax. Please note that any opinions, estimates or forecasts regarding Novavax' performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Novavax or its managment. Novavax does not by its reference above or distribution imply its endorsements of or concurrence with such information, conclusions or recommendations.